The effect of cysteamine bitartrate on adiponectin multimerization in non-alcoholic fatty liver disease and healthy subjects

Journal of Pediatrics

Volumn 161, Issue 4, 2012, Pages

  Dohil, Ranjan ^a   Meyer, Lauren ^a   Schmeltzer, Susanne ^a   Cabrera, Betty L ^a   Lavine, Joel E ^b   Phillips, Susan A ^a  

^a RADY CHILDREN'S HOSPITAL   (United States)

^b Columbia College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; MERCAPTAMINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN TISSUE; MOLECULAR WEIGHT; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 84866742003     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2012.04.011     Document Type: Article

References (31)

1. J.B. Schwimmer, C. Behling, R. Newbury, R. Deutsch, C. Nievergelt, and N.J. Schork Histopathology of pediatric nonalcoholic fatty liver disease Hepatology 42 2005 641 649 (Pubitemid 41233657)
2. C.N. Lumeng, J.L. Bodzin, and A.R. Saltiel Obesity induces a phenotypic switch in adipose tissue macrophage polarization J Clin Invest 117 2007 175 184 (Pubitemid 46048464)
3. Y. Kamada, T. Takehara, and N. Hayashi Adipocytokines and liver disease J Gastroenterol 43 2008 811 822
4. A.J. Sanyal Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease Nat Clin Pract Gastroenterol Hepatol 2 2005 46 53 (Pubitemid 40812527)
5. S. Chitturi, S. Abeygunasekera, G.C. Farrell, J. Holmes-Walker, J.M. Hui, and C. Fung NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome Hepatology 35 2002 373 379 (Pubitemid 34106377)
6. A.J. Sanyal, C. Campbell-Sargent, F. Mirshahi, W.B. Rizzo, M.J. Contos, and R.K. Sterling Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities Gastroenterology 120 2001 1183 1192 (Pubitemid 32246672)
7. S. Shetty, C.M. Kusminski, and P.E. Scherer Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies Trends Pharmacol Sci 30 2009 234 239
8. K. Kantartzis, A. Fritsche, O. Tschritter, C. Thamer, M. Haap, and S. Schafer The association between plasma adiponectin and insulin sensitivity in humans depends on obesity Obes Res 13 2005 1683 1691
9. P.W. Peake, A.D. Kriketos, L.V. Campbell, Y. Shen, and J.A. Charlesworth The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals Eur J Endocrinol 153 2005 409 417 (Pubitemid 41410498)
10. U.B. Pajvani, X. Du, T.P. Combs, A.H. Berg, M.W. Rajala, and T. Schulthess Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity J Biol Chem 278 2003 9073 9085 (Pubitemid 36800387)
11. Z.V. Wang, T.D. Schraw, J.Y. Kim, T. Khan, M.W. Rajala, and A. Follenzi Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention Mol Cell Biol 27 2007 3716 3731 (Pubitemid 46726179)
12. A. Xu, Y. Wang, H. Keshaw, L.Y. Xu, K.S. Lam, and G.J. Cooper The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice J Clin Invest 112 2003 91 100 (Pubitemid 38056380)
13. R. Dohil, S. Schmeltzer, B.L. Cabrera, T. Wang, J. Durelle, and K.B. Duke Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease Aliment Pharmacol Ther 33 2011 1036 1044
14. A.J. Sanyal, N. Chalasani, K.V. Kowdley, A. McCullough, A.M. Diehl, and N.M. Bass Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis N Engl J Med 362 2010 1675 1685
15. J.E. Lavine, J.B. Schwimmer, M.L. Van Natta, J.P. Molleston, K.F. Murray, and P. Rosenthal Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial JAMA 305 2011 1659 1668
16. W.A. Gahl, N. Bashan, F. Tietze, I. Bernardini, and J.D. Schulman Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis Science 217 1982 1263 1265 (Pubitemid 12028677)
17. A. Kessler, M. Biasibetti, D.A. da Silva Melo, M. Wajner, C.S. Dutra-Filho, and A.T. de Souza Wyse Antioxidant effect of cysteamine in brain cortex of young rats Neurochem Res 33 2008 737 744 (Pubitemid 351423138)
18. R. Dohil, M. Fidler, J.A. Gangoiti, F. Kaskel, J.A. Schneider, and B.A. Barshop Twice-daily cysteamine bitartrate therapy for children with cystinosis J Pediatr 156 2010 71 75 e1-3
19. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
20. Y. Kamada, T. Nakamura, T. Funahashi, M. Ryo, H. Nishizawa, and Y. Okauchi Visceral obesity and hypoadiponectinemia are significant determinants of hepatic dysfunction: An epidemiologic study of 3827 Japanese subjects J Clin Gastroenterol 43 2009 995 1000
21. T. Yamauchi, J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, and S. Uchida Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase Nat Med 8 2002 1288 1295 (Pubitemid 35373562)
22. J. Fukushima, Y. Kamada, H. Matsumoto, Y. Yoshida, H. Ezaki, and T. Takemura Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization Hepatol Res 39 2009 724 738
23. T.S. Tsao, E. Tomas, H.E. Murrey, C. Hug, D.H. Lee, and N.B. Ruderman Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways J Biol Chem 278 2003 50810 50817 (Pubitemid 37548930)
24. M. Cortini, and R. Sitia From antibodies to adiponectin: role of ERp44 in sizing and timing protein secretion Diabetes Obes Metab 12 Suppl 2 2010 39 47
25. C.C. Winterbourn, and M.B. Hampton Thiol chemistry and specificity in redox signaling Free Radic Biol Med 45 2008 549 561
26. P. Maher, J. Lewerenz, C. Lozano, and J.L. Torres A novel approach to enhancing cellular glutathione levels J Neurochem 107 2008 690 700
27. T.M. Jeitner, E.J. Delikatny, J. Ahlqvist, H. Capper, and A.J. Cooper Mechanism for the inhibition of transglutaminase 2 by cystamine Biochem Pharmacol 69 2005 961 970 (Pubitemid 40312713)
28. A. Mirza, S.L. Liu, E. Frizell, J. Zhu, S. Maddukuri, and J. Martinez A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-κB Am J Physiol 272 1997 G281 G288
29. L. Qiang, H. Wang, and S.R. Farmer Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulum oxidoreductase Ero1-L alpha Mol Cell Biol 27 2007 4698 4707 (Pubitemid 47016124)
30. D.B. Briggs, R.M. Giron, P.R. Malinowski, M. Nunez, and T.S. Tsao Role of redox environment on the oligomerization of higher molecular weight adiponectin BMC Biochem 12 2011 24 35
31. R. Dohil, M. Fidler, B.A. Barshop, J. Gangoiti, R. Deutsch, and M. Martin Understanding intestinal cysteamine bitartrate absorption J Pediatr 148 2006 764 769 (Pubitemid 43849821)